The Sea Urchin Genome Sequencing Project (SUGSP) Consortium, led by the Human Genome Sequencing Center at Baylor College of Medicine (BCM-HGSC) in Houston, announced today the decoding and analysis of the genome sequence of the sea urchin, Strongylocentrotus purpuratus.
A new Australian study recommends doctors use Google to help diagnose difficult cases, despite indications it’s only 60 per cent accurate. Specialists at Princess Alexandra Hospital in Brisbane studied how effective the world’s largest and most popular search engine is for helping diagnose rare diseases.
Low-carbohydrate diets have been advocated for weight loss and to prevent obesity, but the long-term safety of these diets has not been determined. A study was conducted by Dr. Hu at the Department of Nutrition, Harvard School of Public Health, Boston.
Researchers at the University of Illinois at Chicago College of Pharmacy are attempting to discover how genes determine how well an antipsychotic medication works in adults and children and the side effects it will cause.
Researchers at the Cancer Treatment Centers of America found that antioxidant therapies such as green tea extract, melatonin, high-potency multivitamins, vitamin C and vitamin E do not interfere with radiation treatment.
The Sea Urchin Genome Sequencing Project consortium, led by the Human Genome Sequencing Center at Baylor College of Medicine in Houston, announced today the decoding and analysis of the genome sequence of the sea urchin, Strongylocentrotus purpuratus.
The key to combating AIDS in Russia may be to treat HIV-infected drug users. A new model estimating the spread of HIV in Russia suggests that treating injection drug users with antiretroviral medication will slow transmission of the virus among the general population.
A simple points system may soon help guide treatment of elderly heart failure patients. Researchers at Washington University School of Medicine in St. Louis found that by counting how many of seven easy-to-obtain health factors a patient has, physicians can estimate the patient’s risk of dying.
Minorities account for 30 percent of the U.S. population, but only eight percent of the physician workforce, and experience less personal satisfaction during medical school than nonminority students, finds a Mayo Clinic study published in the November issue of Mayo Clinic Proceedings.
Too much of a signaling protein called insulin-like growth factor-I (IGF-I) may fan the flames of cancer, while too little of the protein may cause short stature, dementia and osteoporosis. New research investigates how the growth hormone/IGF system is affected by the important tumor suppressor gene p53. This interplay of two signaling pathways reinforces questions about the long-term risks of prescribing growth hormone, while suggesting a future new avenue for cancer therapy.